I’m happy to be corrected, but as I understand it Cartrophen is pretty much identical to what we have, although not approved for human use. I doubt therefore that they’ll be any revenue at all from treating pooches.
Ann: 2023 Annual Report and Appendix 4E, page-10
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $99.69M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.5¢ | 28.5¢ | $64.01K | 220.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 25643 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 12428 | 4 |
View Market Depth
| Last trade - 11.41am 08/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |